1jla: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:1jla.png|left|200px]] | [[Image:1jla.png|left|200px]] | ||
{{STRUCTURE_1jla| PDB=1jla | SCENE= }} | {{STRUCTURE_1jla| PDB=1jla | SCENE= }} | ||
===CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651=== | ===CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651=== | ||
{{ABSTRACT_PUBMED_11575933}} | {{ABSTRACT_PUBMED_11575933}} | ||
Line 22: | Line 11: | ||
==See Also== | ==See Also== | ||
*[[Reverse transcriptase]] | *[[Reverse transcriptase|Reverse transcriptase]] | ||
==Reference== | ==Reference== |
Revision as of 17:15, 27 July 2012
CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651
Template:ABSTRACT PUBMED 11575933
About this StructureAbout this Structure
1jla is a 2 chain structure of Reverse transcriptase with sequence from Hiv-1 m:b_hxb2r. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Ren J, Nichols C, Bird L, Chamberlain P, Weaver K, Short S, Stuart DI, Stammers DK. Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors. J Mol Biol. 2001 Sep 28;312(4):795-805. PMID:11575933 doi:http://dx.doi.org/10.1006/jmbi.2001.4988